Search for: "GENENTECH, INC. v. AMGEN INC. " Results 1 - 20 of 36
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Circuit Affirms Grant of Summary Judgement Relating to Invalidity for Lack of Enablement Using Amgen Reasoning:Baxalta Inc. v. GenenTech, Inc.
18 Oct 2023, 4:58 pm by Brittany Leigh
In Amgen Inc. v. [read post]
B2 IP Report - https://b2iplaw.com/blog/
Federal Circuit Affirms Grant of Summary Judgement Relating to Invalidity for Lack of Enablement Using Amgen Reasoning: Baxalta Inc. v. GenenTech, Inc.
2 Nov 2023, 11:32 am by Brittany Leigh
In Baxalta Inc. v. [read post]
B2 IP Report - https://b2iplaw.com/blog/
Baxalta Inc. v. Genentech, Inc.: The Federal Circuit Addresses Enablement After Amgen v. Sanofi
28 Sep 2023, 6:22 am by Warren K. MacRae
Genentech, Inc. [read post]
Real Property & Environmental Law Alert - http://www.rpelawalert.com/
Baxalta Inc. v. Genentech, Inc.: The Federal Circuit Addresses Enablement After Amgen v. Sanofi
28 Sep 2023, 6:22 am by Warren K. MacRae
Genentech, Inc. [read post]
Employment Law Alert - http://www.employmentlawalert.com
Baxalta Inc. v. Genentech, Inc.: The Federal Circuit Addresses Enablement After Amgen v. Sanofi
28 Sep 2023, 6:22 am by Warren K. MacRae
Genentech, Inc. [read post]
IP Law Alert - http://www.iplawalert.com
Genentech, Inc. v. Immunex Rhode Island Corp. (Fed. Cir. 2020)
7 Jul 2020, 8:22 pm by Patent Docs
Noonan -- In a procedurally unusual decision (but one unsurprising in all other respects), the Federal Circuit on Monday affirmed a district court's denial of a temporary restraining order to keep off the market Amgen's biosimilar product Mvasi in Genentech, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Amgen Inc. v. Sandoz Inc, No. 2022-1147 (Fed. Cir. Apr. 19, 2023)
30 Aug 2023, 4:01 pm by Zijian Han
” Thus, citing Genentech, Inc. v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am by Gregory B. Williams
Sleet in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
CAFC interprets Hatch-Waxman in Genentech v. Immunex
10 Jul 2020, 2:12 pm by Lawrence B. Ebert
Amgen Inc., 137 S. [read post]
IPBiz - http://ipbiz.blogspot.com/
Judge Sleet Denies Amgen’s Motion to Transfer Infringement Action to California
27 Jan 2018, 6:40 am by Gregory B. Williams
Sleet in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Enabled to Claim the Unknown? Federal Circuit applies Amgen v. Sanofi to invalidate broad antibody claims
20 Sep 2023, 9:39 am by Dennis Crouch
by Dennis Crouch Baxalta Inc. v. [read post]
Patently-O - https://patentlyo.com
In the Wake of the Supreme Court's Amgen v. Sanofi decision: What’s Next for Biotechnology Claims?
2 Oct 2023, 9:32 pm by Patent Docs
Genentech, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Judge Connolly Issues Claim Construction Opinion for Remaining Disputed Claim Term in Patent-in-Suit in Patent Infringement Action
12 Mar 2020, 2:36 pm by Gregory B. Williams
Connolly in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Judge Connolly Denies Defendant’s Motion to Amend Answer to Add Affirmative Defense that Patent-in-Suit is Unenforceable Due to Plaintiff’s Inequitable Conduct Before the PTO
14 Feb 2020, 12:00 pm by Gregory B. Williams
Connolly in Genentech, Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Amgen and Mircera and the CAFC decision
15 Sep 2009, 10:54 pm
Praxair, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Biosimilars and Temporary Restraining Orders
6 Jul 2020, 8:49 am by Dennis Crouch
[Sandoz Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
USPTO Guidelines: Amgen is a Nothingburger
11 Jan 2024, 12:59 pm by Dennis Crouch
Genentech, Inc., 81 F.4th 1362 (Fed. [read post]
Patently-O - https://patentlyo.com
Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions
4 Aug 2022, 6:56 am by Roberto Rodrigues Pinho (Licks Attorneys), Felipe Mesquita (Licks Attorneys) and Carolina Mendes (Licks Attorneys)
Genentech v. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
20 Dec 2023, 5:00 am by Timothy Bonis
How Amgen v. [read post]
Bill of Health - https://blog.petrieflom.law.harvard.edu/
Not so fast: Phase III Biosimilar Clinical Trial & Infringement Threat does not Create Justiciable Case or Controversy
8 Dec 2014, 12:42 pm by Dennis Crouch
Genentech, Inc., 549 U.S. 118, 127 (2007). [read post]
Patently-O - http://patentlyo.com/patent